Generic Ozempic Canada: Cost, Availability, and What to Know

Generic Ozempic is now available in Canada. After years of anticipation, two true generic versions of semaglutide — the active ingredient in Ozempic — reached the Canadian market in 2026, and are now making their way onto pharmacy shelves. Considering that an estimated three million Canadian adults are taking GLP-1 medications like Ozempic, this is a major development, especially for anyone paying out of pocket.

The two generics come from Dr. Reddy’s Laboratories and Apotex, whose version is sold as Apo-Semaglutide Injection. It’s worth clearing up one early point of confusion: these are genuine third-party generics, which is not the same thing as Plosbrio, a renamed, lower-priced version of Ozempic produced by Novo Nordisk (Ozempic’s original maker).

In this article, we cover where generic Ozempic in Canada stands today, what it costs, how the switch from brand-name Ozempic works, and how semaglutide compares to other GLP-1 medications.

What Is Generic Ozempic?

Ozempic is the brand name for an injectable GLP-1 medication manufactured by Novo Nordisk. The active ingredient of Ozempic is a molecule called semaglutide. Generic Ozempic is that exact same molecule (semaglutide), manufactured by a different pharmaceutical company.

Semaglutide belongs to a class of medications called GLP-1 receptor agonists. It works by mimicking a natural gut hormone that triggers insulin release, slows down digestion, and usually reduces appetite. Officially, semaglutide is prescribed as a once-weekly injection for adults with Type 2 diabetes to help manage blood sugar. However, because it often produces weight loss in people who take it, doctors also prescribe semaglutide off-label for weight management.

To be approved by Health Canada, a generic drug must undergo rigorous testing to prove it is equivalent to the brand-name version. This means generic semaglutide has the same active ingredient, dosage form (injectable), and safety profile as Ozempic. Going forward, generic versions of the medication will probably just be referred to as semaglutide, rather than generic Ozempic.

See our Ultimate Guide to Semaglutide for more detailed information on the molecule, its side effects, and its clinical uses.

Is Generic Ozempic Available in Canada?

Yes. Generic Ozempic is now available in Canada and is rolling out to pharmacies across the country.

Health Canada approved the first generic version of semaglutide, from Dr. Reddy’s Laboratories, on April 28, 2026, making Canada the first G7 country to authorize a generic semaglutide. Three days later, on May 1, Apotex (Canada’s largest domestic drug manufacturer) became the second company to win approval. Apotex commercially launched its product — Apo-Semaglutide Injection — on May 14, and began shipping to pharmacies shortly after. Dr. Reddy’s semaglutide reached select pharmacies around the same time, with both companies expanding distribution nationwide.

Both generics are available in 2 mg and 4 mg prefilled pens designed to work much like the brand-name Ozempic pen. Like branded Ozempic, they’re approved for one official use: a once-weekly injection for adults with Type 2 diabetes to help manage blood sugar. And just like the brand, doctors can also prescribe them off-label for weight management. Because weight-loss prescriptions are rarely covered by public drug plans, this cheaper generic option is exactly what many Canadians paying out of pocket for GLP-1s have been waiting for.

Health Canada is reviewing several more generic semaglutide submissions from other manufacturers, with further approvals expected in the coming months. You can see the current list on Health Canada’s generic submissions under review page.

Why Canada Got Generic Ozempic Early

Canada is the first major global economy to approve generic Ozempic because patent protection on semaglutide expired here years before it will elsewhere.

Novo Nordisk’s foundational patent on semaglutide lapsed in Canada in 2020, after the company missed a mandatory patent maintenance fee. Following that, the eight-year regulatory data exclusivity period ended on January 4, 2026, and a secondary patent covering the injectable formulation expired in March 2026.

Those expired patents opened the legal pathway for Health Canada to authorize generic versions of Ozempic. By contrast, the main US patent on semaglutide doesn’t expire until 2032, and similar patent protections persist across Europe and other major markets.

How the Switch to Generic Semaglutide Works

Once generic semaglutide is available at wholesale, provincial formularies and private insurers trigger mandatory generic substitution. In other words, pharmacists are required to dispense the cheaper generic in place of branded Ozempic on new and refill prescriptions, unless your prescribing doctor specifically writes “no substitution” with a clinical reason.

For most patients with active Ozempic prescriptions, this means you don’t need to do anything to get the generic version. When you next pick up your medication, you may simply receive generic semaglutide. Both Apotex and Dr. Reddy’s have designed pre-filled pens that closely match the experience of using branded Ozempic to make the transition seamless. 

As with any new generic launch, supply will scale up over time, so don’t be surprised if your pharmacy is still dispensing branded Ozempic in the early weeks while inventory turns over.

How Much Does Generic Ozempic Cost in Canada?

Brand-name Ozempic isn’t cheap. Depending on the dose and where you fill it, Canadians paying out of pocket have typically faced several hundred dollars a month (in some cases, more than $450).

Generic semaglutide is meaningfully cheaper. Apotex has said its version is priced at roughly one-third the cost of brand-name Ozempic, and early reporting since launch puts the generic at around $100 a month at many pharmacies.

How Generic Price Drops Work

In Canada, generic drug prices are governed by the pan-Canadian Pharmaceutical Alliance (pCPA), which steps the mandated price down as more generic competitors enter the market. Because two generics arrived almost simultaneously, the market skipped the smallest-discount stage, and prices are expected to fall further as additional manufacturers are approved.

Note: these mechanics set the public drug plan price. What you actually pay at the counter also depends on your provincial coverage, your private insurance, and the dispensing fees and markups at your local pharmacy. For a current, accurate number, ask your pharmacist, as they can tell you what the generic costs and what your plan covers.

Has Brand-Name Ozempic Responded?

Yes. As the generics arrived, Novo Nordisk introduced a savings program that lets eligible patients without public or private drug coverage buy brand-name Ozempic at a price aligned with the generic alternatives. Novo has also registered its own lower-priced versions of the drugs Plosbrio (for diabetes) and Poviztra (for weight loss). The practical upshot is that there are now several cheaper routes to semaglutide for Canadians, and your pharmacist can help you compare what each one will actually cost you.

What If I’m Paying Out of Pocket?

If you’re prescribed generic semaglutide off-label for weight loss, public drug plans won’t cover it, so you’ll pay out of pocket (or through private insurance, if your plan allows).

The good news is that the generic price drop still benefits you directly. Because the underlying wholesale cost of the drug has fallen, the retail price at the pharmacy counter falls too. Therefore, even after markups and dispensing fees, you should pay meaningfully less than the cost of brand-name Ozempic.

How Does Generic Ozempic Compare to Other GLP-1 Medications?

Three GLP-1 medications dominate the Canadian market: Ozempic, Wegovy, and Mounjaro. The differences between them can be a little confusing, especially because two of them are semaglutide-based drugs. For the full landscape, see our GLP-1 Canada guide.

Ozempic vs. Wegovy (Both are Semaglutide)

Both Ozempic and Wegovy are brand names for the same active ingredient: semaglutide. The practical differences are the branding, what they are officially approved for in Canada, and the maximum dose the injection pens can deliver.

• Ozempic (Semaglutide up to 2.0 mg): This is the “diabetes dose.” At the highest 2.0 mg dose, clinical trials showed an average weight loss of 14 pounds (about 7% of body weight). While it may be slightly less potent than Wegovy, the arrival of generic versions means this will be the most affordable GLP-1 option in Canada by a wide margin.
• Wegovy (Semaglutide 2.4 mg): Wegovy is essentially a higher-strength formulation of Ozempic. The Wegovy pen allows for a slightly higher 2.4 mg dose, which pushed average weight loss to 14.9% of body weight in foundational clinical trials. For patients paying out of pocket, the question is whether that extra weight loss is worth paying hundreds of dollars more per month compared to generic Ozempic.

Mounjaro & Zepbound (Branded Tirzepatide)

Mounjaro and Zepbound are brand names for a dual-agonist GLP-1 drug called tirzepatide. Just like the Ozempic and Wegovy split, Mounjaro is tirzepatide branded for diabetes, while Zepbound is the same drug delivered at a higher dose and branded for weight loss.

Tirzepatide produces the highest weight loss seen in any available GLP-1 drug to date — an average of 20.9% of body weight at the highest dose. However, it remains brand-name only and is significantly more expensive than generic semaglutide.

Will There Be a Generic Wegovy or Rybelsus?

Wegovy and Rybelsus are both semaglutide-based medications. But just because generic Ozempic is here, that doesn’t automatically mean generic versions of other semaglutide products are available.

• Generic Wegovy – Health Canada has not yet approved any generic equivalent for the higher 2.4 mg dose of semaglutide found in Wegovy pens. It is unclear if any of the pending applications from manufacturers target this higher dose.
• Generic Rybelsus: The drug uses a proprietary absorption-enhancing technology called SNAC to allow the medicine to work as a tablet. The patents protecting this technology don’t expire in Canada until the 2030s.

Will Generic Ozempic Be Covered by Public Drug Plans?

For Type 2 diabetes, yes. Provincial public drug plans cover semaglutide for diabetes (with criteria that vary by province) and generic versions will be added to those listings as plans update. In BC, for example, PharmaCare covers semaglutide through Special Authority for people with Type 2 diabetes who haven’t reached their blood-sugar targets on metformin — currently up to a 1 mg weekly dose, and not for weight loss.

For patients seeking Ozempic for weight loss, the picture is different.

Currently, Canadian public drug plans do not cover any weight loss medications. This means that even if you get a prescription for an officially approved weight-loss drug like Wegovy or Zepbound, the public system will not cover it.

This lack of public coverage is exactly what makes the arrival of generic Ozempic so important. For Canadians paying out of pocket, the off-label use of cheaper generic semaglutide offers a much more affordable pathway to medically supported weight loss.

Side Effects and Safety of Generic Semaglutide

Because generic semaglutide is biologically identical to branded Ozempic, the side effect profile is exactly the same.

The most common side effects are gastrointestinal, including nausea, vomiting, diarrhea, constipation, and fatigue. These tend to be most pronounced when you first start the medication or step up to a higher dose, and they typically ease as your body adjusts.

For a more detailed look at serious risks, dosing schedules, and what to expect when starting treatment, see our comprehensive Ozempic Canada guide.

Frequently Asked Questions About Generic Semaglutide

When Did Generic Ozempic Launch in Canada?

Generic Ozempic launched in Canada in May 2026. Apotex’s Apo-Semaglutide Injection became commercially available on May 14, and Dr. Reddy’s version reached select pharmacies around the same time. Since then, supply has been scaling up as the products move through distributors to Canada’s pharmacies.

As with any new generic launch, availability rolls out gradually and can vary by region and pharmacy in the early going. If your pharmacy doesn’t have the generic in stock yet, it’s worth asking when they expect it — or checking with another pharmacy nearby.

Is Plosbrio the same as generic Ozempic?

No. Plosbrio is Novo Nordisk’s own renamed, lower-priced version of Ozempic — and Poviztra is its renamed version of Wegovy. They contain the identical formulation, made by the same company; only the name and packaging change. The true third-party generics are Dr. Reddy’s semaglutide and Apotex’s Apo-Semaglutide Injection.

What is Apo-Semaglutide?

Apo-Semaglutide Injection is Apotex’s brand name for its generic version of Ozempic, launched in Canada in May 2026. Apotex is Canada’s largest domestic drug manufacturer. It’s the same molecule (semaglutide) as Ozempic, supplied in 2 mg and 4 mg prefilled pens.

Is generic Ozempic the same as compounded semaglutide?

No, and this is a critical distinction. In Canada, pharmacies are not legally permitted to mass-produce compounded copies of commercially available drugs like Ozempic. Despite this, a “grey market” of compounded semaglutide exists through some medical spas and online retailers. These compounded products often use unapproved salt forms of the molecule and have not undergone Health Canada safety reviews.

Generic Ozempic, by contrast, is a heavily regulated pharmaceutical product. It has been formally approved by Health Canada through the exact same regulatory pathway as branded Ozempic, with a full bioequivalence and safety review.

Will generic Ozempic look different from brand-name Ozempic?

The pens may look slightly different. Both Apotex and Dr. Reddy’s have designed pre-filled pens that closely match the dosing and use experience of branded Ozempic. But the packaging, labelling, and device design will not be identical to the Novo Nordisk product.

Will generic Ozempic be approved for weight loss in Canada?

Not currently. Both approved generic semaglutide products are indicated for Type 2 diabetes management only. Wegovy is the version of semaglutide approved for chronic weight management in Canada, and Wegovy currently remains brand-only. Whether generic versions of the higher-dose Wegovy formulation will be approved in future depends on if manufacturers file for it and successfully clear Health Canada review.

Do I need a new prescription to get generic Ozempic? 

Usually not. If you have an active prescription for Ozempic, pharmacists in Canada are generally required to practice mandatory generic substitution. This means they will automatically dispense the cheaper generic version when you refill, unless your doctor has specifically written “no substitution” on your prescription.

Will my private insurance cover generic Ozempic for weight loss? 

It depends entirely on your specific plan. Just like public plans, many private insurers strictly limit semaglutide coverage to patients with Type 2 diabetes. However, if your private plan currently covers branded Ozempic for weight loss off-label, they will likely require you to switch to the cheaper generic version to maintain your coverage.

Generic Ozempic Canada: The Bottom Line

The arrival of generic Ozempic in Canada is, above all, about access. For the millions of Canadians paying out of pocket — especially for weight management, which public plans don’t cover — a much cheaper version of one of the most effective medications available removes a real financial barrier.

That said, weight management is a complex, highly individual process, and GLP-1 medications aren’t one-size-fits-all. Whether you’re wondering if generic semaglutide is right for you or weighing other options, it’s a decision worth making with a doctor who knows your history.

If you’re in BC, the licensed physicians at Walk In can help. You can speak to a doctor online from the comfort of home to discuss your weight-loss treatment options.

Speak With a Doctor Online About Weight Loss Treatment